Stanley Center & Poitras Center Joint Translational Seminar Series: Dr. Stephan Heckers

April 28, 2015

“How can we make progress in psychiatric research?”

Abstract: In this talk I will combine a review of my own research with a critical reflection on progress made in psychiatry research. My research has focused on mechanisms and consequences of hippocampal dysfunction in schizophrenia and bipolar disorder. While hippocampal pathology is now established as a robust finding in psychotic disorders, it has not yet provided an avenue for better detection nor guided the development of new treatments. When reflecting on how to make progress in psychiatry research, I have become aware of some fundamental misconceptions about psychiatric diagnoses. While psychiatric diagnoses can guide clinical management, they are not good starting points for researchers. I will review several options for how to advance psychiatry research that is not constrained by current models of psychiatric disorder.

Study links brain anatomy, academic achievement, and family income

Many years of research have shown that for students from lower-income families, standardized test scores and other measures of academic success tend to lag behind those of wealthier students.

A new study led by researchers at MIT and Harvard University offers another dimension to this so-called “achievement gap”: After imaging the brains of high- and low-income students, they found that the higher-income students had thicker brain cortex in areas associated with visual perception and knowledge accumulation. Furthermore, these differences also correlated with one measure of academic achievement — performance on standardized tests.

“Just as you would expect, there’s a real cost to not living in a supportive environment. We can see it not only in test scores, in educational attainment, but within the brains of these children,” says MIT’s John Gabrieli, the Grover M. Hermann Professor in Health Sciences and Technology, professor of brain and cognitive sciences, and one of the study’s authors. “To me, it’s a call to action. You want to boost the opportunities for those for whom it doesn’t come easily in their environment.”

This study did not explore possible reasons for these differences in brain anatomy. However, previous studies have shown that lower-income students are more likely to suffer from stress in early childhood, have more limited access to educational resources, and receive less exposure to spoken language early in life. These factors have all been linked to lower academic achievement.

In recent years, the achievement gap in the United States between high- and low-income students has widened, even as gaps along lines of race and ethnicity have narrowed, says Martin West, an associate professor of education at the Harvard Graduate School of Education and an author of the new study.

“The gap in student achievement, as measured by test scores between low-income and high-income students, is a pervasive and longstanding phenomenon in American education, and indeed in education systems around the world,” he says. “There’s a lot of interest among educators and policymakers in trying to understand the sources of those achievement gaps, but even more interest in possible strategies to address them.”

Allyson Mackey, a postdoc at MIT’s McGovern Institute for Brain Research, is the lead author of the paper, which appears the journal Psychological Science. Other authors are postdoc Amy Finn; graduate student Julia Leonard; Drew Jacoby-Senghor, a postdoc at Columbia Business School; and Christopher Gabrieli, chair of the nonprofit Transforming Education.

Explaining the gap

The study included 58 students — 23 from lower-income families and 35 from higher-income families, all aged 12 or 13. Low-income students were defined as those who qualify for a free or reduced-price school lunch.

The researchers compared students’ scores on the Massachusetts Comprehensive Assessment System (MCAS) with brain scans of a region known as the cortex, which is key to functions such as thought, language, sensory perception, and motor command.

Using magnetic resonance imaging (MRI), they discovered differences in the thickness of parts of the cortex in the temporal and occipital lobes, whose primary roles are in vision and storing knowledge. Those differences correlated to differences in both test scores and family income. In fact, differences in cortical thickness in these brain regions could explain as much as 44 percent of the income achievement gap found in this study.

Previous studies have also shown brain anatomy differences associated with income, but did not link those differences to academic achievement.

“A number of labs have reported differences in children’s brain structures as a function of family income, but this is the first to relate that to variation in academic achievement,” says Kimberly Noble, an assistant professor of pediatrics at Columbia University who was not part of the research team.

In most other measures of brain anatomy, the researchers found no significant differences. The amount of white matter — the bundles of axons that connect different parts of the brain — did not differ, nor did the overall surface area of the brain cortex.

The researchers point out that the structural differences they did find are not necessarily permanent. “There’s so much strong evidence that brains are highly plastic,” says Gabrieli, who is also a member of the McGovern Institute. “Our findings don’t mean that further educational support, home support, all those things, couldn’t make big differences.”

In a follow-up study, the researchers hope to learn more about what types of educational programs might help to close the achievement gap, and if possible, investigate whether these interventions also influence brain anatomy.

“Over the past decade we’ve been able to identify a growing number of educational interventions that have managed to have notable impacts on students’ academic achievement as measured by standardized tests,” West says. “What we don’t know anything about is the extent to which those interventions — whether it be attending a very high-performing charter school, or being assigned to a particularly effective teacher, or being exposed to a high-quality curricular program — improves test scores by altering some of the differences in brain structure that we’ve documented, or whether they had those effects by other means.”

The research was funded by the Bill and Melinda Gates Foundation and the National Institutes of Health.

Neuroanatomy Lesson

With the help of neuro artist & grad student Rosa Lafer-Sousa, MIT professor Nancy Kanwisher goes to ludicrous extremes to show you where in the head some of the functionally specific brain regions lie.

Watch more of Nancy’s brain lectures at: http://nancysbraintalks.mit.edu

Bold new microscopies for the brain

McGovern researchers create unexpected new approaches to microscopy that are changing the way scientists look at the brain.

Ask McGovern Investigator Ed Boyden about his ten-year plan and you’ll get an immediate and straight-faced answer: “We would like to understand the brain.”

He means it. Boyden intends to map all of the cells in a brain, all of their connections, and even all of the molecules that form those connections and determine their strengths. He also plans to study how information flows through the brain and to use this to generate a working model. “I’d love to be able to load a map of an entire brain into a computer and see if we can simulate the brain,” he says.

Boyden likens the process to reverse-engineering a computer by opening it up and looking inside. The analogy, though not perfect, provides a sense of the enormity of the task ahead. As complicated as computers are, brains are far more complex, and they are also much harder to visualize, given the need to see features at multiple scales. For example, signals travel from cell to cell through synaptic connections that are measured in nanometers, but the signals are then propagated along nerve fibers that may span several centimeters—a difference of more than a million-fold. Modern microscopes make it possible to study features at one scale or the other, but not both together. Similarly, there are methods for visualizing electrical activity in single neurons or in whole brains, but there is no way to see both at once. So Boyden is building his own tools, and in the process is pushing the limits of imagination. “Our group is often trying to do the opposite of what other people do,” Boyden says.

Boyden’s new methods are part of a broader push to understand the brain’s connectivity, an objective that gained impetus two years ago with the President’s BRAIN Initiative, and with allied efforts such as the NIH-funded Human Connectome Project. Hundreds of researchers have already downloaded Boyden’s recently published protocols, including colleagues at the McGovern Institute who are using them to advance their studies of brain function and disease.

Just add water

Under the microscope, the brain section prepared by Jill Crittenden looks like a tight bundle of threads. The nerve fibers are from a mouse brain, from a region known to degenerate in humans with Parkinson’s disease. The loss of the tiny synaptic connections between these fibers may be the earliest signs of degeneration, so Crittenden, a research scientist who has been studying this disease for several years in the lab of McGovern Investigator Ann Graybiel, wants to be able to see them.

But she can’t. They are far too small— smaller than a wavelength of light, meaning they are beyond the limit for optical microscopy. To bring these structures into view, one of Boyden’s technologies, called expansion microscopy (ExM), simply makes the specimen bigger, allowing it to be viewed on a conventional laboratory microscope.

The idea is at once obvious and fantastical. “Expansion microscopy is the kind of thing scientists daydream about,” says Paul Tillberg, a graduate student in Boyden’s lab. “You either shrink the scientist or expand the specimen.”

Leaving Crittenden’s sample in place, Tillberg adds water. Minutes later, the tissue has expanded and become transparent, a ghostly and larger version of its former self.

Crittenden takes another look through the scope. “It’s like someone has loosened up all the fibers. I can see each one independently, and see them interconnecting,” she says. “ExM will add a lot of power to the tools we’ve developed for visualizing the connections we think are degenerating.”

It took Tillberg and his fellow graduate student Fei Chen several months of brainstorming to find a plausible way to make ExM a reality. They had found inspiration in the work of MIT physicist Toyoichi Tanaka, who in the 1970s had studied smart gels, polymers that rapidly expand in response to a change in environment. One familiar example is the absorbent material in baby diapers, and Boyden’s team turned to this substance for the expansion technique.

The process they devised involves several steps. The tissue is first labeled using fluorescent antibodies that bind to molecules of interest, and then it is impregnated with the gel-forming material. Once the gel has set, the fluorescent markers are anchored to the gel, and the original tissue sample is digested, allowing the gel to stretch evenly in all directions.

When water is added, the gel expands and the fluorescent markers spread out like a picture on a balloon. Remarkably, the 3D shapes of even the finest structures are faithfully preserved during the expansion, making it possible to see them using a conventional microscope. By labeling molecules with different colors, the researchers can even distinguish pre-synaptic from post-synaptic structures. Boyden plans eventually to use hundreds, possibly thousands, of colors, and to increase the expansion factor to 10 times original size, equivalent to a 1000-fold increase in volume.

ExM is not the only way to see fine structures such as synapses; they can also be visualized by electron microcopy, or by recently-developed ‘super-resolution’ optical methods that garnered a 2014 Nobel Prize. These techniques, however, require expensive equipment, and the images are very time-consuming to produce.

“With ExM, because the sample is physically bigger, you can scan it very quickly using just a regular microscope,” says Boyden.

Boyden is already talking to other leading researchers in the field, including Kwanghun Chung at MIT and George Church at Harvard, about ways to further enhance the ExM method. Within the McGovern Institute, among those who expect to benefit from these advances is Guoping Feng, who is developing mouse models of autism, schizophrenia and other disorders by introducing some of the same genetic changes seen in humans with these disorders. Many of the genes associated with autism and schizophrenia play a role in the formation of synapses, but even with the mouse models at his disposal, Feng isn’t sure what goes wrong with them because they are so hard to see. “If we can make parts of the brain bigger, we might be able to see how the assembly of this synaptic machinery changes in different disorders,” he says.

3D Movies Without Special Glasses

Another challenge facing Feng and many other researchers is that many brain functions, and many brain diseases, are not confined to one area, but are widely distributed across the brain. Trying to understand these processes by looking through a small microscopic window has been compared to watching a soccer game by observing just a single square foot of the playing field.

No current technology can capture millisecond-by-millisecond electrical events across the entire living brain, so Boyden and collaborators in Vienna, Austria, decided to develop one. They turned to a method called light field microscopy (LFM) as a way to capture 3D movies of an animal’s thoughts as they flash through the entire nervous system.

The idea is mind-boggling to imagine, but the hardware is quite simple. The instrument records images in depth the same way humans do, using multiple ‘eyes’ to send slightly offset 2D images to a computer that can reconstruct a 3D image of the world. (The idea had been developed in the 1990s by Boyden’s MIT colleague Ted Adelson, and a similar method was used to create Google Street View.) Boyden and his collaborators started with a microscope of standard design, attached a video camera, and inserted between them a six-by-six array of miniature lenses, designed in Austria, that projects a grid of offset images into the camera and the computer.

The rest is math. “We take the multiple, superimposed flat images projected through the lens array and combine them into a volume,” says Young-Gyu Yoon, a graduate student in the Boyden lab who designed and wrote the software.

Another graduate student, Nikita Pak, used the new method to measure neural activity in C. elegans, a tiny worm whose entire nervous system consists of just 302 neurons. By using a worm that had been genetically engineered so that its neurons light up when they become electrically active, Pak was able to make 3D movies of the activity in the entire nervous system. “The setup is just so simple,” he says. “Every time I use it, I think it’s cool.”

The team then tested their method on a larger brain, that of the larval zebra fish. They presented the larvae with a noxious odor, and found that it triggered activity in around 5000 neurons, over a period of about three minutes. Even with this relatively simple example, activity is distributed widely throughout the brain, and would be difficult to detect with previous techniques. Boyden is now working towards recording activity over much longer timespans, and he also envisions scaling it up to image the much more complex brains of mammals.

He hopes to start with the smallest known mammal, the Etruscan shrew. This animal resembles a mouse, but it is ten times smaller, no bigger than a thimble. Its brain is also much smaller, with only a few million neurons, compared to 100 million in a mouse.

Whole brain imaging in this tiny creature could provide an unprecedented view of mammalian brain activity, including its disruption in disease states. Feng cites sensory overload in autism as an example. “If we can see how sensory activity spreads through the brain, we can start to understand how overload starts and how it spills over to other brain areas,” he says.

Visions of Convergence

While Boyden’s microscopy technologies are providing his colleagues with new ways to study brain disorders, Boyden himself hopes to use them to understand the brain as a whole. He plans to use ExM to map connections and identify which molecules are where; 3D whole-brain imaging to trace brain activity as it unfolds in real time, and optogenetics techniques to stimulate the brain and directly record the resulting activity. By combining all three tools together, he hopes to pin stimuli and activity to the molecules and connections on the map and then use that to build a computational model that simulates brain activity.

The plan is grandiose, and the tools aren’t all ready yet, but to make the scheme plausible in the proposed timeframe, Boyden is adhering to a few principles. His methods are fast, capturing information-dense images rapidly rather than scanning over days, and inclusive, imaging whole brains rather than chunks that need to be assembled. They are also accessible, so researchers don’t need to spend large sums to acquire specialized equipment or expertise in-house.

The challenges ahead might appear insurmountable at times, but Boyden is undeterred. He moves forward, his mind open to even the most far-fetched ideas, because they just might work.

Broad Institute-MIT team identifies highly efficient new Cas9 for in vivo genome editing

A collaborative study between researchers from the Broad Institute of MIT and Harvard, Massachusetts Institute of Technology, and the National Center for Biotechnology Information of the National Institutes of Health (NIH-NCBI) has identified a highly efficient Cas9 nuclease that overcomes one of the primary challenges to in vivo genome editing. This finding, published today in Nature, is expected to help make the CRISPR toolbox accessible for in vivo experimental and therapeutic applications.

Originally discovered in bacteria, the CRISPR-Cas9 system enables the cutting of DNA as a defense mechanism against viral infection. Although numerous microbial species possess this system, the Cas9 enzyme from Streptococcus pyogenes (SpCas9) was the first to be engineered for altering the DNA of higher organisms, and has since emerged as the basis for a series of highly versatile genome modification technologies.

Smaller packaging

In order to perturb genes in adult animals, key components of the CRISPR-Cas9 system must be introduced into cells using delivery vehicles known as vectors. Adeno-associated virus (AAV) is considered one of the most promising candidate vectors, as it is not known to cause human disease and has already gained clinical regulatory approval in Europe. However, the small cargo capacity of AAV makes it challenging to package both the SpCas9 enzyme and the other components required for gene editing into a single viral particle.

The Cas9 nuclease from the bacteria Staphylococcus aureus (SaCas9), presented in this new work, is 25% smaller than SpCas9, offering a solution to the AAV packaging problem.

The Broad/MIT team, led by Feng Zhang, core member of the Broad Institute and investigator at the McGovern Institute for Brain Research at MIT, along with collaborators at MIT, led by MIT Institute Professor Phillip Sharp, and the NCBI led by Eugene Koonin, set out to identify smaller Cas9 enzymes that could replicate the efficiency of the current SpCas9 system, while allowing packaging into delivery vehicles such as AAV. The researchers began by using comparative genomics to analyze Cas9s from more than 600 different types of bacteria, selecting six smaller enzymes for further study.

“Sifting through the 600 or so available Cas9 sequences, we identified a group of small variants in which the enzymatic domains were intact whereas the non-enzymatic portion was substantially truncated,” said Eugene Koonin, senior investigator with the NCBI and a contributing author of the study. “Luckily, one of these smaller Cas9 proteins turned out to be suitable for the development of the methodology described in this paper. We are now actively exploring the diversity of Cas9 proteins and their relatives in the hope to find new varieties that could potentially lead to even more powerful tools.”

After rigorous testing, only the Cas9 from S. aureus demonstrated DNA cutting efficiency comparable to that of SpCas9 in mammalian cells. The team then used a method known as BLESS, previously developed by Nicola Crosetto of the Karolinska Institute and Ivan Dikic at the Goethe University Medical School, to determine the presence of unintended “off-targets” across the entire genomic space. Again, SaCas9 and SpCas9 demonstrated comparable DNA targeting accuracy.

The team demonstrated the power of in vivo gene editing with AAV/SaCas9-mediated targeting of PCSK9, a promising drug target. The loss of PCSK9 in humans has been associated with the reduced risk of cardiovascular disease and lower levels of LDL cholesterol. In a mouse model, the team observed almost complete depletion of PCKS9 in the blood one week after administration of AAV/SaCas9 and a 40% decrease in total cholesterol. The mice showed no overt signs of inflammation or immune response.

“While we have chosen a therapeutically relevant target, PCSK9, in this proof-of-principle study, the greater goal here is the development of a versatile and efficient system that expands our ability to edit genomes in vivo,” said Fei Ann Ran, co-first author of the study, along with Le Cong and Winston Yan.

More broadly, SaCas9 is expected improve scientists’ ability to screen for the effects of mutations and better understand gene function using animal models. In the future, it may also be engineered to allow the targeted control of gene expression, which can be employed to expand our understanding of transcriptional and epigenetic regulation in the cell.

The next step, says senior author Feng Zhang, is to compare and contrast the two Cas9s in the hope of recognizing ways to further optimize the system.

“This study highlights the power of using comparative genome analysis to expand the CRISPR-Cas9 toolbox,” said Zhang. “Our long-term goal is to develop CRISPR as a therapeutic platform. This new Cas9 provides a scaffold to expand our Cas9 repertoire, and help us create better models of disease, identify mechanisms, and develop new treatments.”

About the engineered CRISPR-Cas9 system

CRISPRs (Clustered Regularly Interspaced Short Palindromic Repeats) have recently been harnessed as genome editing tools in a wide range of species. The engineered CRISPR-Cas9 system allows researchers to mutate or change the expression of genes in living cells, including those of humans. The family of Cas9 nucleases (also known as Cas5, Csn1, or Csx12) recognizes DNA targets in complex with RNA guides. Researchers can now harness the engineered system to home in on specific nucleic acid sequences and cut the DNA at those precise targets. The cuts modify the activity of the targeted genes, allowing researchers to study the genes’ function.

2015 Scolnick Prize Lecture: Dr. Charles Gilbert

Dr. Charles Gilbert of The Rockefeller University delivers the annual Scolnick Prize Lecture on Friday, March 20, 2015. Charles Gilbert has been a pioneer in understanding the function of visual cortex. His work addresses fundamental questions about visual perception, and has also provided important insights into how the brain recovers from injury and degenerative disease.

2015 McGovern Institute Spring Symposium

Theories of motor control have advanced the idea that the brain uses internal models to generate reliable motor commands and predict the sensory consequences of those commands. More recently, the concept of internal models has been used to formalize the computations that bear on cognitive control in an uncertain and dynamic environment. In this symposium, we will explore the recent advances in the study of internal models in perception, cognition and action, and discuss the extent to which they reveal the common computational principles across neural circuits and behaviors.

DATE: Monday April 27, 2017
TIME: 8:30am – 5:30pm
LOCATION: MIT Bldg 46-3002 (Singleton Auditorium)
QUESTIONS? Laura Halligan | laurahal@mit.edu | 617.715.5396

 

REGISTRATION IS NOW CLOSED

****

2015 Spring Symposium

 

***

8:30 am CONTINENTAL BREAKFAST IN ATRIUM

8:45 – 9:00 am ROBERT DESIMONE & MEHRDAD JAZAYERI, McGovern Institute
Welcoming Remarks

SESSION I Chair: Mark Harnett

9:00 – 9:35 am NATE SAWTELL, Columbia University
Internal model mechanisms in cerebellar circuitry: Insights from electric fish

9:35 – 10:10 am THOMAS JESSELL, Columbia University
Circuits for fast and flexible motor control

10:10 – 10:45 am RICHARD MOONEY, Duke University
Motor – auditory interactions in mice and songbirds

10:45– 11:05 am BREAK

11:05 – 11:40 am KATHLEEN CULLEN, McGill University
Neural correlates of sensory prediction errors: Evidence for internal models of voluntary self-motion in the primate cerebellum

11:40 – 12:15 pm BYRON YU, Carnegie Mellon University
Internal models for interpreting neural population activity during sensori-motor control

12:15 – 1:30 pm POSTER SESSION AND LUNCH

SESSION II Chair: Rebecca Saxe

1:30 – 2:05 pm MARC SOMMER, Duke University
Neuronal circuits for seeing while moving

2:05 – 2:40 pm JÖRN DIEDRICHSEN, University College London
Recalibration or learning de-novo? When to abandon an internal model

2:40 – 3:15 pm AMY BASTIAN, Kennedy Krieger Institute
Cerebellar contributions to moving, sensing and learning

3:15 – 3:35 pm BREAK

3:35 – 4:10 pm DANIEL WOLPERT, University of Cambridge
Internal models for sensorimotor control and decision making

4:10 – 4:45 pm JOSH TENENBAUM, Massachusetts Institute of Technology
The game engine in your head: Modeling common sense-scene understanding with probabilistic programs

4:45 – 5:45 pm PANEL DISCUSSION
Thomas Jessell, Kathleen Cullen, Daniel Wolpert, Josh Tenenbaum

5:45 pm RECEPTION AND POSTER SESSION IN ATRIUM